Prog Med Phys.  2020 Sep;31(S1):S37.

Dosimetric Accuracy of CyberKnife Stereotactic Radiosurgery for Perioptic Lesions

Affiliations
  • 1Radiosurgery Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 2Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 3Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Abstract

Purpose
This study aimed to evaluate the dosimetric accuracy of Cyberknife (CK) for benign perioptic tumor using patient specific QA head phantom.
Methods
Patient specific head phantoms was fabricated using a 3D-printer to be dosimetrically equivalent to actual target regions of benign perioptic tumor case treated via Cyberknife radiosurgery. Using the patient specific QA head phantom, film dosimetry was performed for Cyberknife beam delivery. The measured results were analyzed with the gamma passing rates (GPRs) of 2%/1 mm criteria, by comparing with the calculated dose via the ray-tracing algorithms of the MultiPlan Treatment Planning System (version 5.6). After moved rotating (1 degree) and translating (1–5mm) the couch table prior to beam delivery, we checked the 6D skull tracking accuracy according to the beam irradiation. Phantom QA plan was produced using the original CK contour set (target and optic nerve).
Results
GPRs were greater than the acceptance criteria 80% for all film measurements with the patient specific QA head phantoms in CK perioptic tumor QAs. The difference between measured and calculated dose to the optic nerve in contact with the tumor was less than 3%.
Conclusions
Dosimetric verification with patient-specific head phantoms could be successfully implemented as the evaluation method for CK perioptic tumor radiosurgery delivery.

Keyword

CyberKnife; Perioptic tumor; 6-D skull tracking
Full Text Links
  • PMP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr